These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

509 related articles for article (PubMed ID: 23913125)

  • 1. Specific elimination of mutant mitochondrial genomes in patient-derived cells by mitoTALENs.
    Bacman SR; Williams SL; Pinto M; Peralta S; Moraes CT
    Nat Med; 2013 Sep; 19(9):1111-3. PubMed ID: 23913125
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeted elimination of mutant mitochondrial DNA in MELAS-iPSCs by mitoTALENs.
    Yang Y; Wu H; Kang X; Liang Y; Lan T; Li T; Tan T; Peng J; Zhang Q; An G; Liu Y; Yu Q; Ma Z; Lian Y; Soh BS; Chen Q; Liu P; Chen Y; Sun X; Li R; Zhen X; Liu P; Yu Y; Li X; Fan Y
    Protein Cell; 2018 Mar; 9(3):283-297. PubMed ID: 29318513
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MitoTALEN: A General Approach to Reduce Mutant mtDNA Loads and Restore Oxidative Phosphorylation Function in Mitochondrial Diseases.
    Hashimoto M; Bacman SR; Peralta S; Falk MJ; Chomyn A; Chan DC; Williams SL; Moraes CT
    Mol Ther; 2015 Oct; 23(10):1592-9. PubMed ID: 26159306
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mitochondrially targeted ZFNs for selective degradation of pathogenic mitochondrial genomes bearing large-scale deletions or point mutations.
    Gammage PA; Rorbach J; Vincent AI; Rebar EJ; Minczuk M
    EMBO Mol Med; 2014 Apr; 6(4):458-66. PubMed ID: 24567072
    [TBL] [Abstract][Full Text] [Related]  

  • 5. TALEN-mediated shift of mitochondrial DNA heteroplasmy in MELAS-iPSCs with m.13513G>A mutation.
    Yahata N; Matsumoto Y; Omi M; Yamamoto N; Hata R
    Sci Rep; 2017 Nov; 7(1):15557. PubMed ID: 29138463
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MitoTALEN reduces mutant mtDNA load and restores tRNA
    Bacman SR; Kauppila JHK; Pereira CV; Nissanka N; Miranda M; Pinto M; Williams SL; Larsson NG; Stewart JB; Moraes CT
    Nat Med; 2018 Nov; 24(11):1696-1700. PubMed ID: 30250143
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mitochondrial DNA heteroplasmy in disease and targeted nuclease-based therapeutic approaches.
    Nissanka N; Moraes CT
    EMBO Rep; 2020 Mar; 21(3):e49612. PubMed ID: 32073748
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enhanced mitochondrial DNA editing in mice using nuclear-exported TALE-linked deaminases and nucleases.
    Lee S; Lee H; Baek G; Namgung E; Park JM; Kim S; Hong S; Kim JS
    Genome Biol; 2022 Oct; 23(1):211. PubMed ID: 36224582
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Modulating Mitochondrial DNA Heteroplasmy with Mitochondrially Targeted Endonucleases.
    Mikhailov N; Hämäläinen RH
    Ann Biomed Eng; 2024 Sep; 52(9):2627-2640. PubMed ID: 36001180
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Current strategies towards therapeutic manipulation of mtDNA heteroplasmy.
    Pereira CV; Moraes CT
    Front Biosci (Landmark Ed); 2017 Jan; 22(6):991-1010. PubMed ID: 27814659
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development of a single-chain, quasi-dimeric zinc-finger nuclease for the selective degradation of mutated human mitochondrial DNA.
    Minczuk M; Papworth MA; Miller JC; Murphy MP; Klug A
    Nucleic Acids Res; 2008 Jul; 36(12):3926-38. PubMed ID: 18511461
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The use of mitochondria-targeted endonucleases to manipulate mtDNA.
    Bacman SR; Williams SL; Pinto M; Moraes CT
    Methods Enzymol; 2014; 547():373-97. PubMed ID: 25416366
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Therapeutic Manipulation of mtDNA Heteroplasmy: A Shifting Perspective.
    Jackson CB; Turnbull DM; Minczuk M; Gammage PA
    Trends Mol Med; 2020 Jul; 26(7):698-709. PubMed ID: 32589937
    [TBL] [Abstract][Full Text] [Related]  

  • 14. False positive results of mitochondrial DNA depletion/deletion due to single nucleotide substitutions causing appearance of additional PvuII restriction sites.
    Weglewska-Jurkiewicz A; Jakóbkiewicz-Banecka J; Pronicka E; Wegrzyn G
    Diagn Mol Pathol; 2007 Jun; 16(2):116-20. PubMed ID: 17525683
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Manipulation of mitochondrial genes and mtDNA heteroplasmy.
    Bacman SR; Gammage PA; Minczuk M; Moraes CT
    Methods Cell Biol; 2020; 155():441-487. PubMed ID: 32183972
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gene therapy for mitochondrial disease by delivering restriction endonuclease SmaI into mitochondria.
    Tanaka M; Borgeld HJ; Zhang J; Muramatsu S; Gong JS; Yoneda M; Maruyama W; Naoi M; Ibi T; Sahashi K; Shamoto M; Fuku N; Kurata M; Yamada Y; Nishizawa K; Akao Y; Ohishi N; Miyabayashi S; Umemoto H; Muramatsu T; Furukawa K; Kikuchi A; Nakano I; Ozawa K; Yagi K
    J Biomed Sci; 2002; 9(6 Pt 1):534-41. PubMed ID: 12372991
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Selective elimination of mitochondrial mutations in the germline by genome editing.
    Reddy P; Ocampo A; Suzuki K; Luo J; Bacman SR; Williams SL; Sugawara A; Okamura D; Tsunekawa Y; Wu J; Lam D; Xiong X; Montserrat N; Esteban CR; Liu GH; Sancho-Martinez I; Manau D; Civico S; Cardellach F; Del Mar O'Callaghan M; Campistol J; Zhao H; Campistol JM; Moraes CT; Izpisua Belmonte JC
    Cell; 2015 Apr; 161(3):459-469. PubMed ID: 25910206
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Method for Precisely Identifying Modifications to Plant Mitochondrial Genomes by mitoTALENs.
    Kazama T; Arimura SI
    Methods Mol Biol; 2023; 2615():365-378. PubMed ID: 36807804
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Engineered mtZFNs for Manipulation of Human Mitochondrial DNA Heteroplasmy.
    Gammage PA; Van Haute L; Minczuk M
    Methods Mol Biol; 2016; 1351():145-62. PubMed ID: 26530680
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Selective elimination of mutant mitochondrial genomes as therapeutic strategy for the treatment of NARP and MILS syndromes.
    Alexeyev MF; Venediktova N; Pastukh V; Shokolenko I; Bonilla G; Wilson GL
    Gene Ther; 2008 Apr; 15(7):516-23. PubMed ID: 18256697
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.